Patent directory Β· USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11896617
Polynucleotides encoding rituximab-resistant chimeric antigen receptors
granted -
US 11896643
Fibroblast binding agents and use thereof
granted -
US 11896417
Time-varying kinetic modeling of high temporal-resolution dynamic pet data for multiparametric imaging
granted -
US 11897874
Compounds and methods for modulating Interleukin-2-inducible T-cell kinase
granted -
US 11897945
Methods of treating allergy using anti-Bet v 1 antibodies
granted -
US 11898165
Engineered host cells and methods of use thereof
granted -
US 11898166
In vitro generation of thymic organoid from human pluripotent stem cells
granted -
US 11898207
Methods of isolating neoantigen-specific T cell receptor sequences
granted -
US 11896580
Composition for improving milk quality and preparation method and application thereof
granted -
AU 2022206771
Drug conjugates comprising antibodies against Claudin 18.2
granted -
US 11891426
CD19 variants
granted -
US 11890281
SHP2 phosphatase inhibitors and methods of making and using the same
granted -
US 11890285
Combination therapies
granted -
US 11890289
Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
granted -
US 11890307
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11890320
CLEC11A is a bone growth agent
granted -
US 11890330
Endolysins active against Bacillus bacteria, pharmaceutical compositions, and methods relating thereto
granted -
US 11890353
Anti-polyethylene glycol (PEG) antibody mouse model for rigorous assessment of PEG-based therapies
granted -
US 11890354
Activatable antibodies that bind epidermal growth factor receptor and methods thereof
granted -
US 11890415
Airway management systems for pulmonary disorder treatment
granted -
US 11890344
One-step processing of hydrogels for mechanically robust and chemically desired features
granted -
US 11890359
Zirconia composition, partially sintered material and sintered material and methods for production thereof, and laminate
granted -
US 11891393
Functionalized heterocycles as antiviral agents
granted -
US 11891399
Inhibitors of cancer invasion, attachment, and/or metastasis
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β best for looking up a specific filing or applicant portfolio slice.